Pharmaceutical - UK, Boardroom

Filter

Current filters:

UKBoardroom

Popular Filters

Verona Pharma appoints Biresh Roy as chief financial officer

Verona Pharma appoints Biresh Roy as chief financial officer

30-09-2014

UK respiratory specialist Verona Pharma has appointed Biresh Roy as chief financial officer and member…

BoardroomPharmaceuticalRespiratory and PulmonaryUKVerona Pharma

GlaxoSmithKline confirms Sir Philip Hampton to be chairman

GlaxoSmithKline confirms Sir Philip Hampton to be chairman

25-09-2014

UK pharma giant GlaxoSmithKline this morning confirmed recent rumors, saying that Sir Philip Hampton…

BoardroomGlaxoSmithKlineManagementPharmaceuticalUKUnited Kingdom

Avillion appoints Jarrod Longcor as chief business officer

Avillion appoints Jarrod Longcor as chief business officer

23-09-2014

UK-based Avillion LLP, a co-developer of late-stage pharmaceutical assets, has named Jarrod Longcor as…

Avillion LLPBoardroomBosulifPharmaceuticalUK

Kymab strengthens management team with two senior appointments

Kymab strengthens management team with two senior appointments

03-06-2014

UK-based monoclonal antibody biopharmaceutical company Kymab has announced the appointment of Steve Arkinstall…

BiotechnologyBoardroomKymabPharmaceuticalUK

Ario Pharma strengthens scientific advisory board with two key appointments

Ario Pharma strengthens scientific advisory board with two key appointments

12-05-2014

UK-based biopharmaceutical company Ario Pharma has announced the appointment of Professor Peter Barnes…

BiotechnologyBoardroomPharmaceuticalRespiratory and PulmonaryUK

Rolf Stahel joins Ergomed as Non-Executive Chairman

Rolf Stahel joins Ergomed as Non-Executive Chairman

07-05-2014

UK-based drug development services company Ergomed has announced the appointment of Rolf Stahel to its…

BiotechnologyBoardroomErgomed Clinical ResarchPharmaceuticalUKUSA

GW Pharmaceuticals appoints Kenneth Sommerville as VP, Clinical Science

GW Pharmaceuticals appoints Kenneth Sommerville as VP, Clinical Science

07-05-2014

UK-based GW Pharmaceuticals has announced the appointment of Kenneth Sommerville to the newly created…

BoardroomGW PharmaceuticalsPharmaceuticalUKUSA

Professor Raymond Schinazi joins Board of reViral as Non-executive Director

Professor Raymond Schinazi joins Board of reViral as Non-executive Director

28-04-2014

UK-based antiviral drug discovery and development company reViral has announced the appointment of Professor…

Anti-viralsBiotechnologyBoardroomPharmaceuticalreViralUK

Novartis Vaccines appoints new Medical Affairs Director for North Europe

Novartis Vaccines appoints new Medical Affairs Director for North Europe

25-04-2014

Novartis Vaccines, the vaccination branch of Swiss drug major Novartis (NOVN: VX), has announced the…

BiotechnologyBoardroomNovartisPharmaceuticalUKVaccines

NeRRe Therapeutics announces appointment of Ian Nicholson as Chief Business Officer

NeRRe Therapeutics announces appointment of Ian Nicholson as Chief Business Officer

19-03-2014

UK-based company NeRRe Therapeutics, which is focused on the development of neurokinin (NK) receptor…

BoardroomNeRReTherapeuticsPharmaceuticalUK

Avillion appoints CMO Allison Jeynes-Ellis as chief executive

Avillion appoints CMO Allison Jeynes-Ellis as chief executive

18-02-2014

UK-based drug development company Avillion LLP has appointed Allison Jeynes-Ellis as chief executive.

BoardroombosutinibPharmaceuticalUK

Heptares appoints former GSK research head Tim Tasker as CMO

Heptares appoints former GSK research head Tim Tasker as CMO

10-01-2014

UK-based drug company Heptares Therapeutics has appointed Tim Tasker as chief medical officer and vice…

BoardroomHeptares TherapeuticsPharmaceuticalUK

Kemal Malik appointed Bayer board member with responsibility for innovation

Kemal Malik appointed Bayer board member with responsibility for innovation

20-12-2013

The supervisory board of German drugs and chemicals major Bayer (BAYN: DE) has appointed Kemal Malik…

BayerBiotechnologyBoardroomGermanyPharmaceuticalUK

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

03-12-2013

The UK’s ‘Golden Triangle’ of biotech innovation can compete on the world stage, AstraZeneca (LSE:…

AstraZenecaBoardroomBrilintaInterviewsPharmaceuticalUK

Jonathan Knowles named as executive chairman of the board of Immunocore and Adaptimmune

Jonathan Knowles named as executive chairman of the board of Immunocore and Adaptimmune

20-11-2013

UK-based biotech company Immunocore has appointed Jonathan Knowles as the new executive chairman of the…

AdaptimmuneBoardroomEuropeImmunocoreOncologyPharmaceuticalUK

Interview: Clinigen’s CEO Peter George on the company’s record growth

Interview: Clinigen’s CEO Peter George on the company’s record growth

15-11-2013

If there is one pharma company bucking the trend of shaky financial results it is the Clinigen Group.

BoardroomClinigen GroupFoscavirInterviewsOncologyPharmaceuticalRare diseasesUK

Back to top